FibroGen (FGEN) PT Lowered to $38 at Goldman Sachs
Get Alerts FGEN Hot Sheet
Price: $1.07 --0%
Rating Summary:
3 Buy, 9 Hold, 2 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Rating Summary:
3 Buy, 9 Hold, 2 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on FibroGen (NASDAQ: FGEN) to $38.00 (from $46.00) while maintaining a Neutral rating.
You May Also Be Interested In
- MediaTek Inc. (2454:TT) (MDTKF) PT Lowered to NT$940 at HSBC
- Citizens Financial Group (CFG) PT Raised to $39 at Argus
- Spotify (SPOT) PT Raised to $320 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!